SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-219598
Filing Date
2013-05-14
Accepted
2013-05-14 16:19:18
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d518949d10q.htm 10-Q 548000
2 EX-31.1 d518949dex311.htm EX-31.1 6294
3 EX-31.2 d518949dex312.htm EX-31.2 6228
4 EX-32.1 d518949dex321.htm EX-32.1 3894
  Complete submission text file 0001193125-13-219598.txt   3546052

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alxa-20130331.xml EX-101.INS 390004
6 XBRL TAXONOMY EXTENSION SCHEMA alxa-20130331.xsd EX-101.SCH 36133
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxa-20130331_cal.xml EX-101.CAL 39973
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxa-20130331_def.xml EX-101.DEF 137064
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxa-20130331_lab.xml EX-101.LAB 309873
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxa-20130331_pre.xml EX-101.PRE 223288
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 13841824
SIC: 2834 Pharmaceutical Preparations